A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Neonc Technologies, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Nurix Therapeutics, Inc.
AbbVie
The Netherlands Cancer Institute
Hoosier Cancer Research Network
Nektar Therapeutics
Wake Forest University Health Sciences
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Associació per a la Recerca Oncologica, Spain
Sunnybrook Health Sciences Centre
National Taiwan University Hospital